CGC
NYSECanopy Growth Corporation
SectorHealth CareIndustry Medicinal Chemicals and Botanical Products
News · 26 weeks46+117%
2025-12-282026-06-21
Mix2890d
- Insider11(39%)
- Other8(29%)
- SEC Filings5(18%)
- Leadership2(7%)
- Analyst1(4%)
- Earnings1(4%)
Latest news
25 items- INSIDERDirector Atkins M Shan was granted 108,324 shares, increasing direct ownership by 262% to 149,714 units (SEC Form 4)4 - Canopy Growth Corp (0001737927) (Issuer)
- INSIDERDirector Lazzarato David Angelo was granted 162,485 shares, increasing direct ownership by 226% to 234,533 units (SEC Form 4)4 - Canopy Growth Corp (0001737927) (Issuer)
- INSIDERDirector Bayern Joseph was granted 108,324 shares, increasing direct ownership by 271% to 148,324 units (SEC Form 4)4 - Canopy Growth Corp (0001737927) (Issuer)
- INSIDERDirector Yanofsky Theresa was granted 108,324 shares, increasing direct ownership by 204% to 161,469 units (SEC Form 4)4 - Canopy Growth Corp (0001737927) (Issuer)
- INSIDEROfficer Stewart Thomas Carlton was granted 379,018 shares and sold $9,045 worth of shares (9,285 units at $0.97), increasing direct ownership by 150% to 616,398 units (SEC Form 4) to satisfy withholding tax4 - Canopy Growth Corp (0001737927) (Issuer)
- INSIDEROfficer Gedeon Christelle was granted 396,012 shares and sold $57,466 worth of shares (58,994 units at $0.97), increasing direct ownership by 91% to 705,506 units (SEC Form 4) to satisfy withholding tax4 - Canopy Growth Corp (0001737927) (Issuer)
- INSIDERChief Executive Officer Mongeau Luc was granted 1,056,152 shares and sold $131,729 worth of shares (135,231 units at $0.97), increasing direct ownership by 115% to 1,723,913 units (SEC Form 4) (tax liability)4 - Canopy Growth Corp (0001737927) (Issuer)
- SECSEC Form S-8 filed by Canopy Growth CorporationS-8 - Canopy Growth Corp (0001737927) (Filer)
- SECCanopy Growth Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Canopy Growth Corp (0001737927) (Filer)
- PRCanopy Growth Reports Fourth Quarter and Fiscal Year 2026 Financial Results; Delivers Q4 FY2026 Net Revenue Growth of 27% in Canada Medical and 68% in International Markets CannabisFull-year 2026 growth driven by net revenue increases of 20% in Canada adult-use cannabis and 18% in Canada medical Completed acquisition of MTL Cannabis, positioning Canopy Growth as Canada's leading medical cannabis company by revenue Ended the fiscal year with $131.3M of net cash following strategic recapitalization completed in January 2026 Strategic decisions and financial discipline in FY2026 establish a foundation for acceleration and growth Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC) today announced its financial results for the three months ended March 31, 2026 ("Q4 FY2026") and the fiscal year ended March 31, 2026 ("FY2026"). All fi
- SECSEC Form 10-K filed by Canopy Growth Corporation10-K - Canopy Growth Corp (0001737927) (Filer)
- PRCanopy Growth Announces Claybourne's Frosted Flyers Wins 'Best Infused Pre-Roll' at 2026 Grow Up AwardsClaybourne extends its market share momentum with expanded Frosted Flyers lineup One of Canada's fastest-growing cannabis brands adds new variety formats built for flavour, discovery and summer pre-roll season Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC) today announced that Claybourne's Frosted Flyers Variety Pack has been awarded Best Infused Pre-Roll at the 2026 Grow Up Awards, presented during the annual Grow Up Conference & Expo in Toronto. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260608930080/en/Frosted Flyers Variety Pack Building on that recognition, the Company also anno
- SECSEC Form SD filed by Canopy Growth CorporationSD - Canopy Growth Corp (0001737927) (Filer)
- PRCanopy Growth Relaunches Tweed Brand in Germany with New MTL Cannabis Strain Lineup, Marking First International Release following AcquisitionPablo's Revenge, Dante'z Inferno, and Frost'd Flakes launched under Tweed brand Up to five additional strains expected to follow in June 2026 Company targeting rapid growth in Germany's medical cannabis market Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC) today announced the relaunch of the Tweed brand in the German medical market, alongside the introduction of three cannabis strains developed by MTL Cannabis Corp. ("MTL"), a wholly-owned subsidiary of the Company. The dual milestone represents the Company's first international product release following its recent acquisition of MTL. This press release features multimedia. View the full release
- SECCanopy Growth Corporation filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits8-K - Canopy Growth Corp (0001737927) (Filer)
- SECCanopy Growth Corporation filed SEC Form 8-K: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Canopy Growth Corp (0001737927) (Filer)
- PRCanopy Growth Provides Update on Financial Reporting and Announces Fourth Quarter and Fiscal Year 2026 Financial Results to be Presented on June 15, 2026Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC) expects to release its financial results for the quarter and fiscal year ended March 31, 2026 before financial markets open on June 15, 2026. The Company also announced it plans to file restated financial results for the fiscal years ended March 31, 2025 and March 31, 2024 and to certain of the interim periods therein (the "Refiling"), in conjunction with its filing of financial results for the year ended March 31, 2026 on June 15, 2026, as further described below and in the Company's material change report and the Company's Current Report on Form 8-K each dated May 15, 2026. During the Company's year-end
- PREurope's Cannabis Boom Is Accelerating as Billions Flow into Licensed MarketsNEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- Market News Updates News Commentary - Europe's licensed cannabis industry is starting to look like one of the most exciting growth stories in the global cannabis market. What was once a fragmented, slow-moving sector is now gaining serious momentum as more countries open up medical cannabis programs, expand patient access, and create clearer licensing frameworks for producers and distributors. Germany continues to lead the charge after its cannabis reforms, but countries like the UK, Portugal, Italy, France, Switzerland, and the Czech Republic are also becoming major pieces of the puzzle. Investors and operators are paying close attention because
- PRCanopy Growth and Spectrum Therapeutics Expand Medical Portfolio with New 30 and 90-Pack Softgels and Enhanced Dosing OptionsInformed innovation delivers same trusted quality with improved value, flexible dosing, and better alignment with patient needs Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC) and Spectrum Therapeutics today announced an expansion of its Minor Cannabinoid softgel lineup, introducing new 30 and 90-pack formats and additional dosing options across its Optimized Spectrum portfolio. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260507336358/en/Clarity, Unwind, and Daily Relief 90-pack softgel formats are available now to patients through Spectrum Therapeutics The expansion builds on the strong
- PR'There's a Tweed for That': Canopy Growth Announces Tweed Brand Summer CampaignNew window bags, improved potency, and sharper pricing arrive at retail Victoria Day long weekend Canopy Growth Corporation ("Canopy Growth", "Canopy" or the "Company") (TSX:WEED) (NASDAQ:CGC) today announced a refresh of Tweed, one of Canada's most recognizable cannabis brands, alongside a national summer campaign, "There's a Tweed for That." This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260423388138/en/The Tweed summer campaign launches over the Victoria Day long weekend, the traditional kickoff to the Canadian summer, spotlighting Tweed's updated portfolio, including three new flower strains and the popular Quickies pre-ro
- INSIDERSEC Form 4 filed by Yanofsky Theresa4 - Canopy Growth Corp (0001737927) (Issuer)
- INSIDERSEC Form 4 filed by Atkins M Shan4 - Canopy Growth Corp (0001737927) (Issuer)
- INSIDERSEC Form 4 filed by Bayern Joseph4 - Canopy Growth Corp (0001737927) (Issuer)
- INSIDERSEC Form 4 filed by Lazzarato David Angelo4 - Canopy Growth Corp (0001737927) (Issuer)
- PRCanopy Growth Unveils New Brand 'Deelish': High THC, Everyday Price27%-33% THC flower, and 26%-32% THC pre-rolls across rotating genetics Now available at select stores across Ontario and Alberta Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC) today announced Deelish ("DEE-LISH"), a new cannabis brand built for the everyday consumer with an everyday price. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260331523789/en/High THC, Everyday Price. Deelish is Canopy Growth's newest brand, delivering high THC with flower testing at 27%-33% THC and pre-rolls at 26%-32% THC. Deelish enters the market built to deliver high THC with flower testing at 27%-33% THC a
CGC FAQ
6 questionsWhat does Canopy Growth Corporation do?
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flowers, oils and concentrates, and softgel capsules. It offers its products under the Tweed, Quatreau, Deep Space, Spectrum Therapeutics, First & Free, TWD, This Works, BioSteel, DNA Genetics CraftGrow, Tokyo Smoke, DOJA, Van der Pop...Where does CGC stock trade?
Canopy Growth Corporation (CGC) is listed on NYSE.What sector and industry is CGC in?
Canopy Growth Corporation operates in the Health Care sector, Medicinal Chemicals and Botanical Products industry.What are analysts saying about CGC?
Canopy Growth Corporation has had 8 recent analyst actions on file. The most recent action was from Canaccord Genuity: Buy on 2026-03-27.What companies are similar to CGC?
Notable peers in the same industry include PM (Philip Morris International Inc), BTI (British American Tobacco Industries p.l.c.), MO (Altria Group Inc.), RGC (Regencell Bioscience Holdings Limited), DFTX (Definium Therapeutics Inc.). Compare CGC side-by-side with any of them on Quantisnow.How can I track CGC on Quantisnow?
Quantisnow aggregates Canopy Growth Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow CGC to receive live email and push alerts on every new disclosure.